| Literature DB >> 29382348 |
Sa'ed H Zyoud1,2.
Abstract
BACKGROUND: Tobacco use is a major healthcare problem worldwide. Tobacco smoking remains the most important risk factor for both cancer and heart diseases. This study was initiated due to the lack of published data concerning the real progress in research output in the use of nicotine replacement therapy (NRT) for tobacco cessation. This study was aimed to use bibliometric analysis to estimate the NRT literature indexed in Scopus database at global level.Entities:
Keywords: Bibliometric; NRT; Nicotine replacement therapy; Scopus; Tobacco cessation; Tobacco smoking
Mesh:
Year: 2018 PMID: 29382348 PMCID: PMC5791372 DOI: 10.1186/s12992-018-0335-z
Source DB: PubMed Journal: Global Health ISSN: 1744-8603 Impact factor: 4.185
Fig. 1The total articles included in a bibliometric analysis of worldwide publications related to nicotine replacement therapy for tobacco cessation from 1970 to 2015
Fig. 2Network visualization map of country co-authorships. Of the 56 countries, 35 had at least five publications; the largest set of connected countries consists of 35 countries in 10 clusters
The top 10 ranking of the most productive countries in publishing the largest number of articles associated with nicotine replacement therapy for tobacco cessation during the period from 1970 to 2016
| SCRa | Countries | Articles (%) | Publications per population size in million inhabitants | Publications per | Prevalence of tobacco smokingb | Number of Publications per 100,000 smokers | Collaborations with foreign countries | Number (%)c of documents with international authors | |
|---|---|---|---|---|---|---|---|---|---|
| 1st | United States | 986 (46.1) | 92 | 3.051 | 0.053 | 17.2 | 1.77 | 32 | 127 (12.9) |
| 2nd | United Kingdom | 312 (14.6) | 57 | 4.753 | 0.118 | 19.2 | 2.48 | 21 | 98 (31.4) |
| 3rd | Australia | 102 (4.8) | 25 | 4.227 | 0.085 | 14.9 | 2.84 | 8 | 35 (34.3) |
| 3rd | Sweden | 102 (4.8) | 41 | 10.303 | 0.198 | 20.6 | 5.00 | 19 | 56 (54.9) |
| 5th | Canada | 85 (4.0) | 23 | 2.342 | 0.056 | 14.9 | 1.57 | 6 | 33 (38.8) |
| 6th | France | 51 (2.4) | 16 | 0.762 | 0.021 | 27.6 | 0.28 | 11 | 12 (23.5) |
| 7th | Germany | 49 (2.3) | 13 | 0.593 | 0.014 | 30.3 | 0.20 | 11 | 14 (28.6) |
| 8th | Switzerland | 47 (2.2) | 21 | 5.615 | 0.070 | 23.2 | 2.42 | 9 | 17 (36.2) |
| 9th | Denmark | 41 (1.9) | 22 | 7.155 | 0.134 | 17.0 | 4.21 | 8 | 12 (29.3) |
| 10th | New Zealand | 34 (1.6) | 15 | 7.249 | 0.184 | 16.3 | 4.45 | 6 | 18 (52.9) |
SCR Standard Competition Ranking
aEqual countries have the same ranking number, and then a gap is left in the ranking numbers
bAge-standardized prevalence of current tobacco smoking among people aged 15 years and older [53]
cPercentage of documents with international authors from the total number of documents for each country
Fig. 3Annual number of publications for top 4 productive countries during 1970–2015
The top10 ranking of journals in which articles associated with nicotine replacement therapy for tobacco cessation were published worldwide
| SCRa | Journal | country of journal’s origin | Frequency (%) | IFb | Most productive country (No. of documents-%) |
|---|---|---|---|---|---|
| 1st |
| UK | 143 (6.69) | 4.609 | USA (99-69.2) |
| 2nd |
| UK | 77 (3.60) | 5.789 | USA (34-44.2) |
| 3rd |
| Germany | 61 (2.85) | 3.308 | USA (34-55.7) |
| 4th |
| UK | 54 (2.53) | 2.944 | USA (36-66.7) |
| 4th |
| UK | 54 (2.53) | 5.469 | USA (35-64.8) |
| 6th |
| UK | 37 (1.73) | 20.785 | UK (31-83.8) |
| 7th |
| USA | 33 (1.54) | 44.405 | USA (29-87.9) |
| 8th |
| Netherlands | 28 (1.31) | 3.222 | USA (23-82.1) |
| 9th |
| USA | 27 (1.26) | 17.135 | USA (18-66.7) |
| 10th |
| USA | 25 (1.17) | 4.593 | USA (24-96.0) |
| 10th |
| USA | 25 (1.17) | 3.434 | USA(18-72.0) |
SCR Standard Competition Ranking, IF impact factor
aEqual journals have the same ranking number, and then a gap is left in the ranking numbers
bThe impact factor was reported according to Institute for Scientific Information (ISI) journal citation reports (JCR) 2016
Fig. 4Mapping of terms in the research on nicotine replacement therapy (NRT). a shows the co-occurrence network of terms that extracted from the title or abstract of at least 10 articles. Colors represent groups of terms that are relatively strongly linked to each other. The size of a term signifies the number of publications related to NRT in which the term was appeared, and the distance between two terms represents an estimated indication of the relatedness of these terms. b represents the earlier (blue color) or later (red color) years when the term appeared
The top 10 ranking of cited articles worldwide associated with the use of nicotine replacement therapy for tobacco cessation in Scopus
| SCRa | Authors with year of publication | Title | Source title | Cited by |
|---|---|---|---|---|
| 1st | Jorenby et al., [ | “A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation” |
| 1348 |
| 2nd | Fiore et al., [ | “The effectiveness of the nicotine patch for smoking cessation: A meta-analysis” |
| 547 |
| 3rd | Stead et al., [ | “Nicotine replacement therapy for smoking cessation” |
| 536 |
| 4th | Silagy et al., [ | “Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation” |
| 400 |
| 5th | Benowitz and Gourlay, [ | “Cardiovascular toxicity of nicotine: Implications for nicotine replacement therapy” |
| 381 |
| 5th | Pullan et al., [ | “Transdermal nicotine for active ulcerative colitis” |
| 381 |
| 7th | Joseph et al., [ | “The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease” |
| 379 |
| 8th | Benowitz et al., [ | “Nicotine absorption and cardiovascular effects with smokeless tobacco use: Comparison with cigarettes and nicotine gum” |
| 371 |
| 9th | Kenford et al., [ | “Predicting smoking cessation: Who will quit with and without the nicotine patch” |
| 334 |
| 10th | Stead et al. [ | “Nicotine replacement therapy for smoking cessation” |
| 325 |
SCR Standard Competition Ranking
aEqual articles have the same ranking number, and then a gap is left in the ranking numbers
Top 10 ranking of highly productive institutions that most frequently published articles associated with the use of NRT in tobacco cessation worldwide
| SCRa | Institutions | No. of documents (%) |
|---|---|---|
| 1st | VA Medical Center, USA | 68 (3.18) |
| 2nd | King’s College London, UK | 67 (3.13) |
| 3rd | University of Pittsburgh, USA | 65 (3.04) |
| 4th | University of California, San Francisco, USA | 58 (2.71) |
| 4th | University of Minnesota Twin Cities, USA | 58 (2.71) |
| 6th | University College London, UK | 54 (2.53) |
| 7th | Mayo Clinic, USA | 51 (2.39) |
| 7th | Pinney Associates, USA | 51 (2.39) |
| 9th | University of Vermont, USA | 42 (1.96) |
| 10th | University of Nottingham, UK | 41 (1.92) |
SCR Standard Competition Ranking
aEqual institutions have the same ranking number, and then a gap is left in the ranking numbers
Top ten prolific authors who published the most frequently articles associated with the use of NRT in tobacco cessation worldwide
| SCRa | Author | No. of documents (%) | Affiliation |
|---|---|---|---|
| 1st | Shiffman, S. | 59 (2.76) |
|
| 2nd | Benowitz, N.L. | 54 (2.53) |
|
| 3rd | West, R. | 53 (2.48) |
|
| 4th | Hatsukami, D.K. | 46 (2.15) |
|
| 5th | Hughes, J.R. | 44 (2.06) |
|
| 6th | Hurt, R.D. | 40 (1.87) |
|
| 7th | Croghan, I.T. | 34 (1.59) |
|
| 8th | Tønnesen, P. | 30 (1.40) |
|
| 9th | Lerman, C. | 28 (1.31) |
|
| 10th | Coleman, T. | 26 (1.22) |
|
| 10th | Cummings, K.M. | 26 (1.22) |
|
SCR Standard Competition Ranking
aEqual authors have the same ranking number, and then a gap is left in the ranking numbers
Fig. 5Network visualization map of the authors. Of the 4969 authors, 205 had at least five publications; the largest set of connected authors consists of 195 authors in 16 clusters